Outpatient prescription drug sales of the domestic top 10 companies in March declined and that of multinational pharmaceutical companies increased

On Apr 16, according to the Shinhan Investment Corp., outpatient prescription drug sales in March increased by 2.2% year-on-year and recorded 763.5 billion won. Outpatient prescription drug sales of top pharmaceutical companies in March increased by 1.2% year-on-year and recorded 538.3 billion won. Outpatient prescription drug sales of the domestic top 10 companies declined by 3.3% and recorded...